Atopic Dermatitis: Update on Skin-Directed Management: Clinical Report

Area of Science:

• Dermatology
• Immunology
• Microbiology

Background:

• Atopic dermatitis (AD) affects 20-25% of children, significantly impacting patient and family quality of life.
• Pathogenesis involves a defective skin barrier, immune dysfunction, and altered cutaneous microbiome.
• Current treatments include topical corticosteroids and moisturizers.

Purpose of the Study:

• To summarize current understanding of atopic dermatitis pathogenesis.
• To outline standard and emerging treatment options for AD.
• To emphasize the importance of adherence to treatment plans.

Main Methods:

• Review of recent studies on AD pathogenesis.
• Analysis of standard and emerging therapeutic strategies.
• Discussion of management approaches including trigger reduction and proactive treatment.

Main Results:

• AD involves complex interactions between skin barrier, immune system, and microbiome.
• Topical corticosteroids and moisturizers are standard care.
• Emerging treatments include dupilumab and Janus kinase (JAK) inhibitors.
• Proactive management and adherence are crucial for reducing flares.

Conclusions:

• Effective atopic dermatitis management requires addressing skin barrier defects, immune dysfunction, and microbiome alterations.
• A combination of standard and emerging therapies, alongside trigger avoidance, can improve patient outcomes.
• Simple, clear treatment plans are essential for maximizing patient adherence and managing AD flares.